Does overweight or obesity improve mortality in individuals with established coronary heart disease?
Individuals with established coronary heart disease
Overweight or obesity (assessed by body mass index or true adiposity)
Mortalityhard clinical
This review highlights the debate around the obesity paradox in coronary heart disease, suggesting that limitations of BMI and a potentially protective adipose tissue phenotype may explain the observed survival benefit in overweight or obese patients.
Despite a strong association between body weight and mortality in the general population, clinical evidence suggests better clinical outcome of overweight or obese individuals with established coronary heart disease. This finding has been termed the 'obesity paradox', but its existence remains a point of debate, because it is mostly observed when body mass index (BMI) is used to define obesity. Inherent limitations of BMI as an index of adiposity, as well as methodological biases and the presence of confounding factors, may account for the observed findings of clinical studies. In this review, our aim is to present the data that support the presence of a BMI paradox in coronary heart disease and then explore whether next to a BMI paradox a true obesity paradox exists as well. We conclude by attempting to link the obesity paradox notion to available translational research data supporting a 'healthy', protective adipose tissue phenotype. © 2016 World Obesity.
Building similarity graph...
Analyzing shared references across papers
Loading...
Alexios S. Antonopoulos
Evangelos K. Oikonomou
Charalambos Antoniades
Obesity Reviews
University of Oxford
Science Oxford
Hippocration General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Antonopoulos et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69dd59a580eea7d3f699bb6d — DOI: https://doi.org/10.1111/obr.12440